SCHEMBL27059290

SCHEMBL27059290

CSc1ncc2cc(C(F)F)nc(N3CC4(CCN(C)C4)C3)c2n1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PDE9A O76083 1/20 0.36
▸ FGFR4 P22455 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27035007 0.81 CYP11B2 (0.41) —
SCHEMBL30768119 0.81 CYP11B2 (0.41) —
SCHEMBL29576087 0.80 MEN1 (0.40) FGFR4
SCHEMBL20203405 0.80 MEN1 (0.40) FGFR4
SCHEMBL26341465 0.73 JAK3 (0.35) —
SCHEMBL17056040 0.70 TTK (0.48) PDE9A
SCHEMBL30768115 0.68 HASPIN (0.39) —
SCHEMBL26341306 0.68 HASPIN (0.39) —
SCHEMBL30768105 0.67 CYP11B2 (0.41) —
SCHEMBL17056048 0.66 TTK (0.43) FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024020419-A1 AZA-QUINAZOLINE COMPOUNDS AND METHODS OF USE IAMBIC THERAPEUTICS, INC. (US) 2024-01-25 — — WO disclosed
Send feedback